Regulation of EPC-1/PEDF in normal human fibroblasts is posttranscriptional
The EPC‐1 (early population doubling level cDNA‐1) gene, also known as pigment epithelium‐derived factor, encodes a protein belonging to the serine protease inhibitor (serpin) superfamily that has been reported to inhibit angiogenesis and proliferation of several cell types. We have previously repor...
Saved in:
Published in | Journal of cellular biochemistry Vol. 79; no. 3; pp. 442 - 452 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
New York
John Wiley & Sons, Inc
07.09.2000
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The EPC‐1 (early population doubling level cDNA‐1) gene, also known as pigment epithelium‐derived factor, encodes a protein belonging to the serine protease inhibitor (serpin) superfamily that has been reported to inhibit angiogenesis and proliferation of several cell types. We have previously reported that the EPC‐1 mRNA and the secreted EPC‐1 protein are expressed at levels more than 100‐fold higher in early passage, G0, WI‐38 cells compared to either proliferating or senescent WI‐38 fibroblasts. To examine the molecular mechanisms that regulate changes in EPC‐1 gene expression in WI‐38 cells, we isolated and characterized the human EPC‐1 gene and determined the mRNA cap site. Transcriptional assays showed no change in the transcription rates of EPC‐1 between young proliferating, quiescent, and senescent WI‐38 cells. These results suggest posttranscriptional regulation of the EPC‐1 gene. Reverse transcriptase polymerase chain reaction measurements (of hnRNA) indicate regulation at the hnRNA level. The regulation of the EPC‐1 gene at the level of hnRNA can explain the observed slow increase in the steady‐state EPC‐1 mRNA levels when cells become quiescent. The reduction of EPC‐1 mRNA levels that occurs when cells exit G0 and are induced to proliferate can be accounted for by a reduction of the EPC‐1 mRNA stability in stimulated cells as compared to quiescent cells. J. Cell. Biochem. 79:442–452, 2000. © 2000 Wiley‐Liss, Inc. |
---|---|
Bibliography: | National Cancer Institute - No. CA68923 National Institute on Aging - No. AG000378; No. AG00532 istex:B22E2887B2AC6D7F8D5BF4B5A8DE00F0138975B6 ark:/67375/WNG-5C7VCC13-N ArticleID:JCB90 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0730-2312 1097-4644 |
DOI: | 10.1002/1097-4644(20001201)79:3<442::AID-JCB90>3.0.CO;2-Z |